Biological restoration of central nervous system architecture and function: part 3-stem cell- and cell-based applications and realities in the biological management of central nervous system disorders: traumatic, vascular, and epilepsy disorders.
STEM CELL THERAPY has emerged as a promising novel therapeutic endeavor for traumatic brain injury, spinal cord injury, stroke, and epilepsy in experimental studies. A few preliminary clinical trials have further supported its safety and early efficacy after transplantation into humans. Although not yet clinically available for central nervous system disorders, stem cell technology is expected to evolve into one of the most powerful tools in the biological management of complex central nervous system disorders, many of which currently have limited treatment modalities. The identification of stem cells, discovery of neurogenesis, and application of stem cells to treat central nervous system disorders represent a dramatic evolution and expansion of the neurosurgeon's capabilities into the neurorestoration and neuroregeneration realms. In Part 3 of a 5-part series on stem cells, we discuss the theory, experimental evidence, and clinical data pertaining to the use of stem cells for the treatment of traumatic, vascular, and epileptic disorders.
Farin
Azadeh
A
Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. azadehfarin@hotmail.com
Liu
Charles Y
CY
Langmoen
Iver A
IA
Apuzzo
Michael L J
ML
D000818:Animals; D001930:Brain Injuries / Q000628:therapy*; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000628:therapy*; D006801:Humans; D013119:Spinal Cord Injuries / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods*; D020521:Stroke / Q000628:therapy*